References
- ADAMS HP, Jr., BRorr TG, CROWELL RM, FURLAN AJ, •GOMEZ CR, GROTTA J, HELGASON CM, MARLER JR,WOOLSON RF, ZINVIN JA, FEINBERG W, MAYBERG M. Guidelines for the management of patients with acute ischemic stroke - a statement for healthcare profes-sional from a special writing group of the stroke coun-cil, American Heart Association. Circulation (1994) 90:1588–1601.
- Excellent overview of current view on the therapeutic possibilities for acute stroke treatment.
- ADAMS 11P, Jr., WOOLSON RE, BILLER J, CLARKE W: Studies ••of Org 10172 in patients with acute ischemic stroke.Ilaernostasis (1992) 22:99–103.
- A review of the potential of this heparinoid in stroke teatment and an introduction to the TOAST trial.
- ELLER J, MASSEY EW, MARLER JR, ADAMS TIP, Jr., DAVISJN, BRUNO A, HENRIKSON RA, LINHARDT RH, GOLDSTEIN LB, ALBERTS M, KISKER CT, TOFFOL GJ, GREENBERG CS, BAI\TWART KJ, BERTELS C, BECK DW, WALKER M, MAG-NANI IIN: A dose escalation study of Org 10172 (low molecular weight heparinoid) in stroke. Neurology (1989) 39:262–265.
- MASSEY EW, BILLER J, DAVIS JN, ADAMS HP, Jr., MARLERJR, GOLDSTEIN LB, ALBERTS M, EARLE N, BRUNO A: Large-dose infusions of heparinoid Org 10172 in is-chemic stroke. Stroke (1990) 21:1289–1292.
- MEULEMAN DG, HOBBELEN PMJ, VAN DEDEM G, MOELKER fiCT: A novel antithrombotic heparinoid (Org 10172) devoid of bleeding inducing capadty: a survey of its parmacological properties in experimental ani-mal models. Tbromb. Res. (1982) 27:353–363.
- GORDON DL, LINHARDT R, ADAMS HP, Jr.: Low-molecu-lar-weight hepatitis and heparinoids and their use in acute or progressing ischemic stroke. Clin. Neuropbar-macol. (1990) 13(6):522–543.